Background: The Silk Vista Baby (SVB) flow diverter (FDS) is the only FDS deliverable via a 0.017 inch microcatheter and is specifically designed for the distal vasculature. We sought to evaluate the safety and efficacy of the SVB.

Materials And Methods: We performed a retrospective review to identify SVB cases at 4 tertiary neurosurgical centres within the U.K. Clinical, procedural, angiographic and follow-up data were collected.

Results: We identified 60 patients (35 female, 58%) of average age 54 ± 10.5 (range 30-72) with 61 aneurysms, 50 (81.9%) located in the anterior circulation. The majority of the aneurysms treated were unruptured (46, 75.4%) and saccular (46, 75.4%). Dome size was 6.2 ± 6.2 mm (range 1-36mm) and parent vessel diameter was 2.3 ± 0.4 mm (range 1.2-3.3 mm).An average number of 1.07 devices were implanted. Coils or other devices were implanted in 14 aneurysms (23.3%). At last angiographic follow-up (n = 55), 7.5 ± 4.2 months post-procedure, 32 aneurysms (57.1%) were graded as RRC I, 7 (12.5%) RRC II, and 17 RRC III (30.4%).Clinical complications, excluding death, were seen in 4 patients (6.8%) including 1 delayed aneurysm rupture and 3 symptomatic ischaemic events. Only one patient had permanent morbidity (mRS 1). 3 patients died during follow-up (5.1%); 2 deaths were related to the aneurysms (3.4%) - one ruptured dissecting MCA aneurysm, and one giant partially thrombosed posterior circulation aneurysm. 93% of patients were mRS ≤ 2 at last follow-up.

Conclusion: The SVB has high rates of technical success and an acceptable safety profile. Distal aneurysms may occlude slower due to relative oversizing of the devices.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131493PMC
http://dx.doi.org/10.1177/15910199211024061DOI Listing

Publication Analysis

Top Keywords

silk vista
8
vista baby
8
angiographic follow-up
8
devices implanted
8
aneurysms
6
baby experience
4
experience background
4
background silk
4
baby svb
4
svb flow
4

Similar Publications

Phosphate-Driven Interfacial Self-Assembly of Silk Fibroin for Continuous Noncovalent Growth of Nanothin Defect-Free Coatings.

ACS Appl Mater Interfaces

October 2024

Department of Chemical and Biological Engineering, 110 Eighth Street, Rensselaer Polytechnic Institute, Troy, New York 12180, United States.

Silk fibroin is a fiber-forming protein derived from the thread of silkworm cocoons. This biocompatible protein, under the kosmotropic influence of potassium phosphate, can undergo supramolecular self-assembly driven by a random coil to β-sheet secondary structure transition. By leveraging concurrent nonspecific adsorption and self-assembly of silk fibroin, we demonstrate an interfacial phenomenon that yields adherent, defect-free nanothin protein coatings that grow continuously in time, without observable saturation in mass deposition.

View Article and Find Full Text PDF
Article Synopsis
  • There is a lack of evidence on the safety of flow diversion (FD) for treating aneurysms outside the circle of Willis, leading to a study on the Silk Vista Baby (SVB) device at a single medical center.
  • The study involved 57 patients with various types of aneurysms, mostly in the anterior circulation, and found a low complication rate (5.2% symptomatic ischemic) with no hemorrhagic incidents and an overall mortality rate of 1.8%.
  • The findings suggest that SVB is a safe option for treating both distal anterior and complex posterior fossa aneurysms, but further multicenter studies are necessary to validate these results.
View Article and Find Full Text PDF

Background And Objectives: Iatrogenic cerebrovascular injury can cause intracranial hemorrhage and pseudoaneurysm formation, putting patients at high risk for postoperative bleeding. No consensus for management exists. This study describes endovascular treatment of these acute injuries with flow diverter stents.

View Article and Find Full Text PDF

Background: Flow diverting stents (FDS) have transformed the treatment of intracranial aneurysms; however, their metallic structure associated with their intra-luminal positioning hamper angiographic and clinical outcomes. Therefore, there is a need to develop FDS with optimized surfaces that reduce thrombogenicity while promoting the healing process and endothelialization.

Methods: P8RI, a peptide mimicking the CD31 protein, was previously developed and grafted onto Silk Vista (SV) FDS.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluates the effectiveness and safety of the Silk Vista Baby (SVB) flow diverter for treating small cerebral aneurysms, focusing on long-term follow-up.
  • Researchers analyzed data from 50 patients treated with the SVB between September 2018 and June 2021, noting a low complication rate of 8% during procedures.
  • Results showed a 100% technical success rate, no re-ruptures, and a high occlusion rate of 94% at the 12-month follow-up, confirming the SVB as a safe and effective treatment option.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!